- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 235/08 - Radicals containing only hydrogen and carbon atoms
Patent holdings for IPC class C07D 235/08
Total number of patents in this class: 476
10-year publication summary
|
35
|
40
|
40
|
39
|
33
|
30
|
32
|
29
|
23
|
6
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Idemitsu Kosan Co., Ltd. | 3995 |
43 |
| LG Chem, Ltd. | 17205 |
9 |
| AstraZeneca AB | 3042 |
9 |
| Array BioPharma Inc. | 551 |
9 |
| Theravance Biopharma R&D IP, LLC | 550 |
9 |
| Allergan, Inc. | 2600 |
8 |
| Glaxosmithkline LLC | 566 |
7 |
| Merck Patent GmbH | 5909 |
7 |
| Merck Sharp & Dohme Corp. | 2247 |
6 |
| Janssen Pharmaceutica N.V. | 3839 |
5 |
| Nycomed GmbH | 87 |
5 |
| Pfizer Inc. | 3322 |
4 |
| Bayer Pharma AG | 1096 |
4 |
| The General Hospital Corporation | 4517 |
4 |
| Takeda Pharmaceutical Company Limited | 2961 |
4 |
| Ecolab USA Inc. | 5190 |
4 |
| MEI Pharma, Inc. | 80 |
4 |
| Neomed Institute | 17 |
4 |
| Nippon Shinyaku Co., Ltd. | 297 |
4 |
| Pfizer Japan Inc. | 32 |
4 |
| Other owners | 323 |